Syncona

Investment thesis

FTSE 250 closed-ended life science investment company (LSE: SYNC), co-founded with the Wellcome Trust, that founds, builds and funds healthcare companies delivering transformational treatments in areas of high unmet need. Its permanent-capital structure lets it back companies from formation through clinical development.

Notable portfolio

Sector focus